Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Cancers|August 5, 2025
Correction: Cloître et al. Spatial Distribution of Recurrence and Long-Term Toxicity Following Dose Escalation to the Dominant Intra-Prostatic Nodule for Intermediate-High-Risk Prostate Cancer: Insights from a Phase I/II Study. <i>Cancers</i> 2024, <i>16</i>, 2097Minna Cloître, Sofian Benkhaled, Sarah Boughdad, et al.
Cancers|April 13, 2023
Independent Reproduction of the FLASH Effect on the Gastrointestinal Tract: A Multi-Institutional Comparative StudyAnet Valdés Zayas, Neeraj Kumari, Kevin Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|May 4, 2025
Average Dose Rate is the Major Temporal Beam Structure Parameter for Preserving Murine Intestines with Pulsed Electron FLASH-RTVeljko Grilj, Anet Valdes Zayas, Anouk Sesink, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 2, 2026
A phase I dose escalation of FLASH radiotherapy in patients with cutaneous metastases from melanoma: The IMPulse trialRémy Kinj, Luis Schiappacasse, Veljko Grilj, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991Michel Bolla, Philippe Maingon, Christian Carrie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 26, 2021
Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk DiseaseMichel Bolla, Anouk Neven, Philippe Maingon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2026
Combinatorial delivery of low-dose radiotherapy and immunotherapy to patients with immune-excluded tumors enhances CD8+ T cell functionalityMaria Ochoa-de-Olza, Nicolas Rayroux, Martina Imbimbo, et al.
Oncoimmunology|December 19, 2024
Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7<sup>th</sup> immunorad conferencePierre-Antoine Laurent, Fabrice André, Alexandre Bobard, et al.
Oncoimmunology|May 22, 2025
Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad ConferenceFereshteh Talebi, Fabiana Gregucci, Jalal Ahmed, et al.
Cancer Discovery|September 4, 2021
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to ImmunotherapyFernanda G Herrera, Catherine Ronet, Maria Ochoa de Olza, et al.
Pageof 5